LataMed AI (LMED) Shares Outstanding (Weighted Average) (2023 - 2026)

LataMed AI has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $56.1 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $56.1 million, up 91.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.1 million (up 91.74% YoY), and the FY2025 annual result was $44.3 million, up 51.3% from the prior year.
• Shares Outstanding (Weighted Average) came in at $56.1 million for Q1 2026 at LataMed AI, up from $44.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $56.1 million in Q1 2026 to a low of $190299.0 in Q2 2023.
• The 4-year median for Shares Outstanding (Weighted Average) is $14.8 million (2023), against an average of $18.2 million.
• Peak annual rise in Shares Outstanding (Weighted Average) reached 11321.47% in 2024, while the deepest fall reached 5.21% in 2024.
• LataMed AI's Shares Outstanding (Weighted Average) stood at $256332.0 in 2023, then jumped by 11321.47% to $29.3 million in 2024, then surged by 51.3% to $44.3 million in 2025, then grew by 26.72% to $56.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $56.1 million (Q1 2026), $44.3 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.